Brexpiprazole (Rexulti) is effective for treating agitation associated with Alzheimer's dementia (AAD), but appears to carry the increased risk for death observed with other antipsychotics in elderly ...

For many people living with dementia and their caregivers, the worst symptom of the disease is not memory loss, but agitation. Whether it comes out as verbal insults or physical violence, agitation in ...

In trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast ...